Results for Pediatric Pulmonology

1 - 10 of 23

Dr. Ren's primary research focus is to develop better methods to assess lung disease in infants and young children using advanced pulmonary function testing and imaging.

E-mail:

renc [at] chop.edu

Maureen B. Josephson, DO

E-mail:

josephsonm [at] chop.edu

Oscar H. Mayer, DO

Dr. Mayer's research interests center on chronic respiratory failure, the pulmonary manifestations of neuromuscular disease, and assessing and managing patients with complex chest wall and spine disease.

E-mail:

mayero [at] chop.edu

Melissa S. Xanthopoulos, MS, PhD

Dr. Xanthopoulos's research focuses on the development, implementation, and adherence to medical and lifestyle interventions, including non-invasive ventilation (CPAP/BPAP), eating habits, physical activity, and sleep. She has a particular interest in the interactions among behavioral, lifestyle, psychosocial and physiologic factors as they relate to health and neurobehavioral functioning and quality of life in youth and families.

E-mail:

xanthop [at] chop.edu

Sharon McGrath-Morrow, MBA, MD

Dr. McGrath-Morrow is associate chief of the Division of Pulmonary and Sleep Medicine and leader of the Post-preemie Lung Disease Clinic at Children’s Hospital of Philadelphia. Her research seeks to link early life events with adult lung health and biomarker discovery for future trials.

E-mail:

mcgrathmos [at] chop.edu

Suzanne E. Beck, MD

E-mail:

becksu [at] chop.edu

Ignacio E. Tapia, MD

Dr. Tapia's research program focuses on understanding the central nervous system complications of obstructive sleep apnea in children.

E-mail:

tapia [at] chop.edu

Samuel B. Goldfarb, MD

Dr. Goldfarb has special interests in the treatment of children with end-stage lung disease such as cystic fibrosis, interstitial lung disease, pulmonary late effects of oncology treatments, and other pulmonary disorders.

E-mail:

goldfarb [at] chop.edu

Stamatia Alexiou, MD

E-mail:

alexious1 [at] chop.edu

Ronald C. Rubenstein, MD, PhD

Dr. Rubenstein's research focuses on basic and translational studies of novel means to improve outcomes in cystic fibrosis. He initially focused on correcting the dysfunction of mutant cystic fibrosis transmembrane conductance regulator (CFTR) proteins, which led him to study how molecular chaperones regulate the biogenesis and trafficking of CFTR and other proteins that are relevant to cystic fibrosis.

E-mail:

rubensteinr [at] chop.edu